Cargando…
Ivermectin induced Steven–Johnsons syndrome: case report
BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adul...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422988/ https://www.ncbi.nlm.nih.gov/pubmed/28482929 http://dx.doi.org/10.1186/s13104-017-2500-5 |
_version_ | 1783234877748936704 |
---|---|
author | Aroke, Desmond Tchouakam, Diego Nitcheu Awungia, Alexis Tazinya Mapoh, Sylvester Yari Ngassa, Stewart Ndutard Kadia, Benjamin Momo |
author_facet | Aroke, Desmond Tchouakam, Diego Nitcheu Awungia, Alexis Tazinya Mapoh, Sylvester Yari Ngassa, Stewart Ndutard Kadia, Benjamin Momo |
author_sort | Aroke, Desmond |
collection | PubMed |
description | BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. CONCLUSION: Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection. |
format | Online Article Text |
id | pubmed-5422988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54229882017-05-12 Ivermectin induced Steven–Johnsons syndrome: case report Aroke, Desmond Tchouakam, Diego Nitcheu Awungia, Alexis Tazinya Mapoh, Sylvester Yari Ngassa, Stewart Ndutard Kadia, Benjamin Momo BMC Res Notes Case Report BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. CONCLUSION: Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection. BioMed Central 2017-05-08 /pmc/articles/PMC5422988/ /pubmed/28482929 http://dx.doi.org/10.1186/s13104-017-2500-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Aroke, Desmond Tchouakam, Diego Nitcheu Awungia, Alexis Tazinya Mapoh, Sylvester Yari Ngassa, Stewart Ndutard Kadia, Benjamin Momo Ivermectin induced Steven–Johnsons syndrome: case report |
title | Ivermectin induced Steven–Johnsons syndrome: case report |
title_full | Ivermectin induced Steven–Johnsons syndrome: case report |
title_fullStr | Ivermectin induced Steven–Johnsons syndrome: case report |
title_full_unstemmed | Ivermectin induced Steven–Johnsons syndrome: case report |
title_short | Ivermectin induced Steven–Johnsons syndrome: case report |
title_sort | ivermectin induced steven–johnsons syndrome: case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422988/ https://www.ncbi.nlm.nih.gov/pubmed/28482929 http://dx.doi.org/10.1186/s13104-017-2500-5 |
work_keys_str_mv | AT arokedesmond ivermectininducedstevenjohnsonssyndromecasereport AT tchouakamdiegonitcheu ivermectininducedstevenjohnsonssyndromecasereport AT awungiaalexistazinya ivermectininducedstevenjohnsonssyndromecasereport AT mapohsylvesteryari ivermectininducedstevenjohnsonssyndromecasereport AT ngassastewartndutard ivermectininducedstevenjohnsonssyndromecasereport AT kadiabenjaminmomo ivermectininducedstevenjohnsonssyndromecasereport |